17 results on '"Elizabeth M. Burke"'
Search Results
2. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
- Author
-
Filippo Pinto e Vairo, Jennifer L. Kemppainen, Carolyn R. Rohrer Vitek, Denise A. Whalen, Kayla J. Kolbert, Kaitlin J. Sikkink, Sarah A. Kroc, Teresa Kruisselbrink, Gabrielle F. Shupe, Alyssa K. Knudson, Elizabeth M. Burke, Elle C. Loftus, Lorelei A. Bandel, Carri A. Prochnow, Lindsay A. Mulvihill, Brittany Thomas, Dale M. Gable, Courtney B. Graddy, Giovanna G. Moreno Garzon, Idara U. Ekpoh, Eva M. Carmona Porquera, Fernando C. Fervenza, Marie C. Hogan, Mireille El Ters, Kenneth J. Warrington, John M. Davis, Matthew J. Koster, Amir B. Orandi, Matthew L. Basiaga, Adrian Vella, Seema Kumar, Ana L. Creo, Aida N. Lteif, Siobhan T. Pittock, Peter J. Tebben, Ejigayehu G. Abate, Avni Y. Joshi, Elizabeth H. Ristagno, Mrinal S. Patnaik, Lisa A. Schimmenti, Radhika Dhamija, Sonia M. Sabrowsky, Klaas J. Wierenga, Mira T. Keddis, Niloy Jewel J. Samadder, Richard J. Presutti, Steven I. Robinson, Michael C. Stephens, Lewis R. Roberts, William A. Faubion, Sherilyn W. Driscoll, Lily C. Wong-Kisiel, Duygu Selcen, Eoin P. Flanagan, Vijay K. Ramanan, Lauren M. Jackson, Michelle L. Mauermann, Victor E. Ortega, Sarah A. Anderson, Stacy L. Aoudia, Eric W. Klee, Tammy M. McAllister, and Konstantinos N. Lazaridis
- Subjects
Rare disease ,Undiagnosed disease ,Individualized medicine ,Genomics ,Genetic counseling ,Medicine - Abstract
Abstract Background In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion of RD has an underlying genetic cause; however, this may go undiagnosed. To better serve these patients, the Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD) was created under the auspices of the Center for Individualized Medicine (CIM) aiming to integrate genomics into subspecialty practice including targeted genetic testing, research, and education. Methods Patients were identified by subspecialty healthcare providers from 11 clinical divisions/departments. Targeted multi-gene panels or custom exome/genome-based panels were utilized. To support the goals of PRaUD, a new clinical service model, the Genetic Testing and Counseling (GTAC) unit, was established to improve access and increase efficiency for genetic test facilitation. The GTAC unit includes genetic counselors, genetic counseling assistants, genetic nurses, and a medical geneticist. Patients receive abbreviated point-of-care genetic counseling and testing through a partnership with subspecialty providers. Results Implementation of PRaUD began in 2018 and GTAC unit launched in 2020 to support program expansion. Currently, 29 RD clinical indications are included in 11 specialty divisions/departments with over 142 referring providers. To date, 1152 patients have been evaluated with an overall solved or likely solved rate of 17.5% and as high as 66.7% depending on the phenotype. Noteworthy, 42.7% of the solved or likely solved patients underwent changes in medical management and outcome based on genetic test results. Conclusion Implementation of PRaUD and GTAC have enabled subspecialty practices advance expertise in RD where genetic counselors have not historically been embedded in practice. Democratizing access to genetic testing and counseling can broaden the reach of patients with RD and increase the diagnostic yield of such indications leading to better medical management as well as expanding research opportunities.
- Published
- 2023
- Full Text
- View/download PDF
3. Utilization of the Ballast Long Guiding Sheath for Neuroendovascular Procedures: Institutional Experience in 68 Cases
- Author
-
Ameer E. Hassan, Elizabeth M. Burke, Marlon Monayao, and Wondwossen G. Tekle
- Subjects
endovascular therapy ,aneurysm ,stroke ,stent ,long guiding sheath ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: The rise of neurointerventional devices has created a demand for guide systems capable of navigating to the carotid artery consistently regardless of tortuosity. The shift toward large distal access catheters (DACs) and desire for greater trackability have inspired the creation of flexible, supportive, large-lumen long guiding sheaths. Recently, the Ballast long guiding sheath was introduced to provide stability and flexibility while navigating neurointerventional devices through tortuous intracranial anatomy.Objective: To report our experience using the Ballast long guiding sheath in a series of patients undergoing a variety of neuroendovascular procedures.Methods: We retrospectively identified all patients who underwent neuroendovascular treatment with a long guiding sheath were selected from a prospectively maintained endovascular database from January 2019 to November 2019. Baseline clinical characteristics and procedural details were collected.Results: A total of 68 patients were included, mean patient age 67.6 ± 13.6 years. Of the patients treated, 52.9% (36/68) presented with stenosis, 25% (17/68) with aneurysms, 13.2% (9/68) with stroke or emboli, 1.5% (1/68) with a tumor, 1.5% (1/68) with an arteriovenous fistula (AVF), and 4.4% (3/68) with a carotid web. Of the patients with stenosis, 20/36 (55.6%) were extracranial, and 16/36 (44.4%) were intracranial. The Ballast long guiding sheath was used to deliver treatment devices for stenting (37/68, 54.4%), flow diversion (12/68, 17.6%), mechanical thrombectomy (8/68, 11.8%), endovascular coiling (5/68, 7.4%), liquid embolization (3/68, 4.4%), balloon angioplasty (2/68, 2.9%), and balloon angioplasty with stenting (1/68, 1.5%). No Ballast-related complications or adverse events were encountered.Conclusions: We demonstrate the feasibility of the Ballast long guiding sheath to successfully deliver modern neurointerventional treatment devices through tortuous anatomy.
- Published
- 2021
- Full Text
- View/download PDF
4. Visualization of flow diverter stent wall apposition during intracranial aneurysm treatment using a virtually diluted cone beam CT technique (Vessel ASSIST)
- Author
-
Ameer E Hassan, Wondwossen G Tekle, Jim Wise, and Elizabeth M. Burke
- Subjects
Flow diverter stent ,Cone beam computed tomography ,medicine.diagnostic_test ,business.industry ,Digital subtraction angiography ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Apposition ,0302 clinical medicine ,Aneurysm treatment ,Medicine ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,Nuclear medicine ,business ,030217 neurology & neurosurgery ,Cone beam ct ,Flow diverter ,Neuroradiology - Abstract
Flow diverters (FD) have poor radiopacity, challenging visualization of deployment and vessel wall apposition with conventional neuroimaging modalities. We evaluated a novel cone beam computed tomography (CT) imaging technique that allows virtual dilution (VD) of contrast media to facilitate workflow and ensure accurate assessment of FD wall apposition. We retrospectively evaluated all patients treated for intracranial aneurysms with FD at our institution between November 2018 and November 2019. Undiluted injected dual cone beam CT acquisitions performed post-stenting were displayed with VD software (GE Healthcare). The resulting images were compared with conventional two-dimensional (2D) digital subtraction angiography (DSA) images. Two neurointerventionalists (Reader 1 and Reader 2, (R1, R2)) independently assessed FD deployment and wall apposition. Confidence in the diagnosis, inter-reader agreement, and X-ray exposure were assessed. A total of 27 cases were reviewed. FD deployment and wall apposition scores were 4.2 ± 1.0 (R1) and 4.0 ± 1.1 (R2) for DSA and 3.7 ± 1.2 (R1) and 4.1 ± 1.0 (R2) for VD. Confidence in the diagnosis was improved with VD, with scores of 3.7 ± 0.7 (R1) and 4.0 ± 0.7 (R2) using DSA and 4.9 ± 0.2 (R1) and 4.9 ± 0.2 (R2) using VD (P
- Published
- 2020
5. Adenosine-induced transient asystole to control intraoperative rupture of intracranial aneurysms: institutional experience and systematic review of the literature
- Author
-
Leslie A. Nussbaum, Elizabeth M. Burke, and Eric S. Nussbaum
- Subjects
Male ,medicine.medical_specialty ,Adenosine ,Aneurysm, Ruptured ,03 medical and health sciences ,0302 clinical medicine ,Aneurysm ,Internal medicine ,Humans ,Medicine ,Transient (computer programming) ,Asystole ,business.industry ,Intracranial Aneurysm ,General Medicine ,Middle Aged ,Subarachnoid Hemorrhage ,medicine.disease ,Heart Arrest ,030220 oncology & carcinogenesis ,Heart Arrest, Induced ,Cardiology ,Female ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Intraoperative rupture of an intracranial aneurysm is a life-threatening situation that carries a high risk of morbidity and mortality. Since 2000, adenosine has been used successfully to induce transient hypotension and/or asystole to control bleeding and facilitate surgical clipping of aneurysms that rupture intraoperatively. Given the paucity of reports describing this method in a limited number of patients, we performed a systematic review of the literature detailing the use and outcomes of this technique.The authors performed a systematic review and identified all studies in which adenosine was used in the setting of an intracranial aneurysm that ruptured intraoperatively. We then determined overall morbidity and mortality rates, adding an additional six of our own patients.Data was analyzed for a total of 29 patients, including 23 previously reported patients from the literature and 6 additional cases from our own experience (mean age 54.8 years, 58.6% female). Most patients (82.8%, 24/29) presented with subarachnoid hemorrhage (SAH). Overall mean dose of adenosine was 51.8 mg. Successful clipping was achieved in 100% of patients. Transient or permanent morbidity was reported in 5/29 (17.2%) and the overall mortality rate was 31% (9/29), which occurred primarily due to an initial severe SAH and its resultant complications.Adenosine-induced circulatory arrest appears to safely control intraoperative bleeding and facilitate the clipping of ruptured intracranial aneurysms based on the limited published literature available. Further studies comparing patient outcomes using this technique to traditional approaches are required to validate the safety and efficacy of adenosine in this high-risk setting.
- Published
- 2020
6. CT cisternography to visualize epidermoid tumors for stereotactic radiosurgery treatment planning
- Author
-
Elizabeth M. Burke, Leslie A. Nussbaum, Collin M Torok, Eric S. Nussbaum, and Camille A. Schwarzrock
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Computed tomography ,CT cisternography ,Neuroimaging ,Radiosurgery ,Sensitivity and Specificity ,03 medical and health sciences ,0302 clinical medicine ,Physiology (medical) ,otorhinolaryngologic diseases ,medicine ,Humans ,Radiation treatment planning ,medicine.diagnostic_test ,business.industry ,Brain Neoplasms ,Epidermoid tumor ,Magnetic resonance imaging ,General Medicine ,Neurology ,030220 oncology & carcinogenesis ,Surgery ,Neurology (clinical) ,Radiology ,business ,Tomography, X-Ray Computed ,030217 neurology & neurosurgery - Abstract
The visualization of intracranial epidermoid tumors is often limited by difficulties associated with distinguishing the tumor from the surrounding cerebrospinal fluid using traditional computed tomography (CT) or magnetic resonance imaging (MRI) modalities. This report describes our experience using CT cisternography to visualize intracranial epidermoid tumors in three illustrative cases. CT cisternography of the epidermoid tumor provides more clarity and precision compared to traditional neuroimaging modalities. We demonstrate the feasibility of using CT cisternography to produce high-resolution images with well-defined tumor margins that can be used effectively for precise SRS treatment planning.
- Published
- 2021
7. Neonatal apneic phenotype in a murine congenital central hypoventilation syndrome model is induced through non‐cell autonomous developmental mechanisms
- Author
-
Sakima A. Smith, Michele Joana Alves, Jillian Liu, Lisa A. Baer, Caroline C. Szujewski, Talita M. Silva, Mikayla Jones, Mehmet Tahir Aslan, Jose Otero, Thiago S. Moreira, Catherine Czeisler, Alfredo J. Garcia, Jessica Blackburn, Amber Kempton, Kristin I. Stanford, Jean-Charles Viemari, Diego Alzate-Correa, Marina Y. Shimada, Jessica Zuniga, Giuliana Zaza, Ana C. Takakura, Abby Silbaugh, Behiye Kaya, Silvio A. Fernandes-Junior, Elizabeth M. Burke, Institut de Neurosciences de la Timone (INT), and Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Neurogenesis ,[SDV]Life Sciences [q-bio] ,Biology ,Congenital central hypoventilation syndrome ,PHOX2B ,Pathology and Forensic Medicine ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Maldevelopment ,medicine ,Animals ,Research Articles ,Progenitor ,Homeodomain Proteins ,Motor Neurons ,FENÓTIPOS ,General Neuroscience ,Genetic disorder ,respiratory rhythm-generating networks ,Nkx2.2 ,chemosensation ,Hypoventilation ,respiratory rhythm‐generating networks ,congenital central hypoventilation syndrome (CCHS) ,Motor neuron ,apnea ,medicine.disease ,Sleep Apnea, Central ,Neuroepithelial cell ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Phenotype ,Animals, Newborn ,Homeobox ,Neurology (clinical) ,Brainstem ,Neuroscience ,030217 neurology & neurosurgery ,Transcription Factors ,Research Article - Abstract
International audience; Congenital central hypoventilation syndrome (CCHS) represents a rare genetic disorder usually caused by mutations in the homeodomain transcription factor PHOX2B. Some CCHS patients suffer mainly from deficiencies in CO 2 and/or O 2 respiratory chemoreflex, whereas other patients present with full apnea shortly after birth. Our goal was to identify the neuropathological mechanisms of apneic presentations in CCHS. In the developing murine neuroepithelium, Phox2b is expressed in three discrete progenitor domains across the dorsal-ventral axis, with different domains responsible for producing unique autonomic or visceral motor neurons. Restricting the expression of mutant Phox2b to the ventral visceral motor neuron domain induces marked newborn apnea together with a significant loss of visceral motor neurons, RTN ablation, and preBötzinger complex dysfunction. This finding suggests that the observed apnea develops through non-cell autonomous developmental mechanisms. Mutant Phox2b expression in dorsal rhombencephalic neurons did not generate significant respiratory dysfunction, but did result in subtle metabolic thermoregulatory deficiencies. We confirm the expression of a novel murine Phox2b splice variant which shares exons 1 and 2 with the more widely studied Phox2b splice variant, but which differs in exon 3 where most CCHS mutations occur. We also show that mutant Phox2b expression in the visceral motor neuron progenitor domain increases cell proliferation at the expense of visceral motor neuron development. We propose that visceral motor neurons may function as organizers of brainstem respiratory neuron development, and that disruptions in their development result in secondary/ non-cell autonomous maldevelopment of key brainstem respiratory neurons.
- Published
- 2020
8. Re-epithelialization of Porcine Skin By The Sweat Apparatus
- Author
-
Stanley J. Miller, Robert M. Lavker, Michael D. Rader, Pierre A. Coulombe, and Elizabeth M. Burke
- Subjects
Keratinocytes ,Pathology ,medicine.medical_specialty ,keratinization ,intrinsic divergence ,Swine ,Dermatology ,Biology ,Biochemistry ,Sweat gland ,Skin Physiological Phenomena ,medicine ,Animals ,Molecular Biology ,Skin ,Wound Healing ,integumentary system ,environmental modulation ,Surgical wound ,Epithelial Cells ,Anatomy ,Cell Biology ,Hair follicle ,Epithelium ,Sweat Glands ,medicine.anatomical_structure ,Phenotype ,Epidermis ,Wound healing ,Keratinocyte ,epithelial stem cells - Abstract
The behavior of the keratinocyte during the initial stages of cutaneous wound repair has been the subject of intense investigation. Most of these studies have focused on the lateral edges of wounds as the source of activated keratinocytes. Less attention has been directed towards elucidating the role of the appendageal structures as sources of keratinocytes for re-epithelialization, particularly the sweat apparatus. Surgical wounds of specific depths were created in pig skin, above and below hair follicles, and wound healing was allowed to take place in a setting in which lateral ingrowth of keratinocytes by migration was prevented. In this manner, all re-epithelialization occurred from residual appendageal structures. In those wounds where only sweat gland elements remained, an epithelium formed that had clinical, morphologic, and protein electrophoretic features closer to palmar/plantar or mucosal-like epithelia. In contrast, wounds that retained elements of the hair follicle healed faster and the resultant epithelium clinically, morphologically, and biochemically resembled the surrounding nonwounded epidermis. These findings establish that the sweat apparatus is capable of re-epithelializing the skin surface after a major cutaneous wound, but may not be capable of mimicking the epidermis.
- Published
- 1998
- Full Text
- View/download PDF
9. Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy
- Author
-
Sharon Caplan, Elizabeth M. Burke, John E. Croghan, and Susan Denman
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Pilot Projects ,Aspiration pneumonia ,Pneumonia, Aspiration ,Speech and Hearing ,Enteral Nutrition ,Swallowing ,medicine ,Humans ,Prospective cohort study ,Feeding tube ,Aged ,Retrospective Studies ,business.industry ,Mortality rate ,Gastroenterology ,Videotape Recording ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Nursing Homes ,Surgery ,Pneumonia ,Otorhinolaryngology ,Fluoroscopy ,Female ,Deglutition Disorders ,business - Abstract
The 12-month clinical outcomes of nursing home patients who underwent videofluoroscopic swallowing evaluation was determined. A retrospective review of 40 patients in a teaching nursing home who had videofluoroscopic swallowing studies from 1987 through 1989 was performed. Clinical outcomes measured included feeding tube placement, rehospitalization within 1 year, prolonged nursing home stay (>6 months), pneumonia, and pneumonia death. It was determined if outcomes were associated with the presence of aspiration on videofluoroscopy and subsequent feeding tube placement. In the 12-month follow-up period, 17 of 40 patients (43%) who underwent videofluoroscopic swallowing evaluation developed pneumonia and 18 of 40 (45%) died. Twenty-two patients demonstrated aspiration on videofluoroscopy. Increased rehospitalization was the only outcome measure that was associated with the presence of aspiration on videofluoroscopy (p≤0.05). Of 22 patients with aspiration, 15 had feeding tubes placed. This group had a higher rate of pneumonia (p≤0.05) and pneumonia death (p≤0.05) compared with the 7 patients with aspiration who did not receive feeding tubes. Patients with nasogastric tubes had a higher death rate (7/9) than patients with gastrostomy tubes (2/8; p≤0.05), but similar rates of rehospitalization and pneumonia. Nursing home patients who underwent videofluoroscopic swallowing evaluation had poor clinical outcomes at 12 months, regardless of their test results. Though limited by its small size and retrospective nature, this pilot study questions whether videofluoroscopic swallowing studies accurately identify patients at risk for developing aspiration pneumonia and whether feeding tubes prevent aspiration or improve clinical outcomes. A larger, prospective study is needed to address these issues.
- Published
- 1994
10. Altered transcriptional regulation of human interstitial collagenase in cultured skin fibroblasts from older donors
- Author
-
Walter E. Horton, Elizabeth M. Burke, George R. Martin, Michael T. Crow, and Jay D. Pearson
- Subjects
Adult ,Male ,Aging ,DNA, Complementary ,Adolescent ,Transcription, Genetic ,Recombinant Fusion Proteins ,Biology ,Matrix metalloproteinase ,Transfection ,Biochemistry ,Endocrinology ,Genetics ,medicine ,Humans ,Collagenases ,RNA, Messenger ,Promoter Regions, Genetic ,Fibroblast ,Molecular Biology ,Cells, Cultured ,Cellular Senescence ,Aged ,Glycoproteins ,Skin ,Aged, 80 and over ,Messenger RNA ,Reporter gene ,Tissue Inhibitor of Metalloproteinases ,Cell Biology ,Fibroblasts ,Tissue inhibitor of metalloproteinase ,Molecular biology ,medicine.anatomical_structure ,Enzyme Induction ,Collagenase ,Tetradecanoylphorbol Acetate ,Interstitial collagenase ,Female ,Wound healing ,medicine.drug - Abstract
Primary human dermal fibroblasts isolated from the medial aspect of the proximal forearm of young and old donors were compared for the expression of interstitial collagenase, 72 kDa type IV collagenase, the tissue inhibitor of metalloproteinase type 1, and pro-α2 (I) collagen mRNA at basal levels and after stimulation with the tumor promotor 12- O -tetradecanoyl-phorbol-13-acetate. Higher basal and induced steady-state mRNA levels of interstitial collagenase were found in the cells from older donors. Ratios of basal and induced steady-state mRNA levels of interstitial collagenase to pro-α2 (I) collagen, and interstitial collagenase to the tissue inhibitor of metalloproteinases type 1 were also higher in the cells from older donors. Seventy-two kiloDalton type IV collagenase and pro-α2 (I) collagen mRNA showed similar levels of expression in the cells from young and old donors and were not altered by treatment with 12- O -tetradecanoyl-phorbol-13-acetate. Transient transfection assays with the interstitial collagenase promoter linked to a reporter gene showed increased activity of the reporter in cell strains with high interstitial collagenase mRNA levels. Mobility shift assays demonstrated increased binding activity to the specific 12- O -tetradecanoyl-phorbol-13-acetate response element in nuclear extracts from the cell strains with higher induced collagenase mRNA levels and higher reporter gene activity. These findings are consistent with the observed phenotype of interstitial collagenase and its specific tissue inhibitor in the senescent fibroblast aging model.
- Published
- 1994
11. Identification of estrogen receptor mRNA and the estrogen modulation of parathyroid hormone-stimulated cyclic AMP accumulation in opossum kidney cells
- Author
-
Elizabeth M. Burke, Jay R. Shapiro, David B. Danner, James A. Coderre, John L. Stock, and Stewart D. Chipman
- Subjects
Male ,medicine.medical_specialty ,Physiology ,medicine.drug_class ,Molecular Sequence Data ,Clinical Biochemistry ,Estrogen receptor ,Parathyroid hormone ,Biology ,Cell Line ,Phosphates ,Kidney Tubules, Proximal ,Internal medicine ,Cyclic AMP ,medicine ,Animals ,Humans ,RNA, Messenger ,Aged ,Aged, 80 and over ,Kidney ,Base Sequence ,Estradiol ,Cell growth ,Biological Transport ,DNA ,Opossums ,Cell Biology ,Antiestrogen ,Peptide Fragments ,Kinetics ,Endocrinology ,medicine.anatomical_structure ,Receptors, Estrogen ,Parathyroid Hormone ,Cell culture ,Estrogen ,hormones, hormone substitutes, and hormone antagonists ,Intracellular - Abstract
The opossum kidney (OK) cell was used as a model to test the hypothesis that estrogen directly affects proximal renal tubular epithelial cells. To demonstrate the expression of estrogen receptor in OK cells, we developed an approach using reverse transcription and the polymerase chain reaction. Analysis of the DNA amplified with nested primers revealed the predicted size fragment and restriction enzyme digestion products. To demonstrate the functional effects of estrogen, OK cells at confluence were preincubated in serum-free medium for 7-10 days with or without 17 beta-estradiol. Bovine PTH(1-34) (bPTH(1-34)) then stimulated a dose-dependent intracellular accumulation of cAMP that was maximal after 1 min and then gradually declined. Cyclic AMP in the medium slowly increased over 60 min. Preincubation with 17 beta-estradiol did not affect cell proliferation as measured by total protein content but caused an inhibition of bPTH(1-34)-stimulated intracellular cAMP accumulation that was maximal at 10(-11) M 17 beta-estradiol (71 +/- 3% control, p less than .001). bPTH(1-34) also increased cAMP release into the medium, an effect maximal using 10(-10) M 17 beta-estradiol (118 +/- 3% control, p less than .001). Preincubation with the inactive isomer 17 alpha-estradiol caused no changes in cAMP accumulation or release. Coincubation with the antiestrogen tamoxifen blocked the effects of 17 beta-estradiol. Sodium-dependent phosphate transport was: (1) inhibited by 2-h incubations with 10(-8) or 10(-10) M bPTH(1-34) and not affected by preincubation with 17 beta-estradiol, and (2) not inhibited by a 20-min incubation with 10(-8) M bPTH(1-34) unless cells were preincubated with 10(-8) M 17 beta-estradiol, suggesting that any possible effects of estrogen on phosphate transport are not directly mediated by changes in cAMP. These studies demonstrate the presence of estrogen receptor mRNA in OK cells as well as direct and specific effects of physiologic concentrations of estrogen on cAMP accumulation in these cells. This system may be a good model for further study of estrogen and PTH effects on the kidney.
- Published
- 1992
12. Changes in fibronectin mRNA splicing with in vitro passage
- Author
-
David B. Danner and Elizabeth M. Burke
- Subjects
Messenger RNA ,Base Sequence ,biology ,RNA Splicing ,Molecular Sequence Data ,Alternative splicing ,Biophysics ,DNA ,Cell Biology ,Fibroblasts ,Polymerase Chain Reaction ,Biochemistry ,Molecular biology ,FNDC5 ,Reverse transcriptase ,Cell Line ,Fibronectins ,Fibronectin ,Real-time polymerase chain reaction ,RNA splicing ,biology.protein ,Humans ,RNA, Messenger ,Precursor mRNA ,Molecular Biology - Abstract
Senescent human fibroblasts produce larger fibronectin molecules with altered binding properties. To determine if this change could involve alternative splicing of fibronectin precursor mRNA, we developed an approach using reverse transcription and the polymerase chain reaction to study fibronectin mRNA splicing at each of the three alternatively spliced regions. Two of the three regions showed changes with in vitro passage; incorporation of the ED-A region increased 8 fold.
- Published
- 1991
13. Zosteriform papular eruption. Zosteriform lichen planus
- Author
-
Susan D. Laman, Margaret S. O'Neill, and Elizabeth M. Burke
- Subjects
Male ,Papular eruption ,medicine.medical_specialty ,business.industry ,Skin Diseases, Papulosquamous ,Lichen Planus ,Dermatology ,General Medicine ,Zosteriform lichen planus ,Medicine ,Humans ,business ,Aged - Published
- 1997
14. Hair Loss in a 5-Year-Old Boy
- Author
-
Susan E. Koch and Elizabeth M. Burke
- Subjects
medicine.medical_specialty ,integumentary system ,business.industry ,Dermatology ,General Medicine ,medicine.disease ,Surgery ,Lesion ,medicine.anatomical_structure ,Hair loss ,Scalp ,medicine ,Tinea capitis ,Differential diagnosis ,medicine.symptom ,business ,Mycosis - Abstract
REPORT OF A CASE A 5-year-old white boy was referred for evaluation of a solitary patch of hair loss, which had begun 8 weeks earlier. Initially, he had presented to his primary care physician with an inflamed plaque of alopecia involving the left frontal area. He was treated with oral antibiotics, with minimal response. Owing to persistence of the lesion, the patient was referred for further evaluation and treatment. On examination, a 3×3-cm, erythematous, crusted, scaling patch with broken hairs was present on the front part of the scalp (Figure 1). Purulent drainage and follicular pustules were absent. The social history was significant for 2 healthy cats and 1 dog at home. Wood light fluorescence was absent. A potassium hydroxide preparation of scrapings from the involved scalp and hairs was nondiagnostic. A fungal culture of broken hairs and scale showed some growth in 5 days. A mature colony plated on
- Published
- 1997
15. Nonhealing Ulcers on the Lower Extremities
- Author
-
Thomas Horn, Richard L. Humphrey, and Elizabeth M. Burke
- Subjects
medicine.medical_specialty ,Pathology ,medicine.diagnostic_test ,Anti-nuclear antibody ,business.industry ,Hepatitis C virus ,Physical examination ,Dermatology ,General Medicine ,Hepatitis B ,medicine.disease ,medicine.disease_cause ,Gastroenterology ,Cryoglobulinemia ,Serology ,Edema ,Internal medicine ,Liver biopsy ,medicine ,medicine.symptom ,business - Abstract
REPORT OF A CASE A 40-year-old white woman presented with a 3-month history of painful, nonhealing ulcers on her lower extremities. Her medical history was remarkable for hepatitis C virus (HCV) infection. Her physical examination revealed multiple 1- to 5-cm discrete ulcers with surrounding hyperpigmented macules on the lower extremities ( Figure 1 ). The pulses in the lower extremities were full, symmetrical, and without bruits. Trace edema of the lower extremities was present without cyanosis. Diagnostic workup and laboratory tests revealed the following: HCV antigen (Ag) was detected in the serum sample by polymerase chain reaction; serum transaminase and alkaline phosphatase levels were moderately elevated; findings of a liver biopsy were consistent with active hepatitis; the antinuclear antibody (Ab) titer was 1:40; serologic tests were negative for hepatitis B Ab and Ag and anticardiolipin antibody and positive for HCV Ab; and the serum ceruloplasmin and α 1 -antitrypsin activity were
- Published
- 1997
16. Zosteriform Papular Eruption
- Author
-
Susan D. Laman, Margaret S. O'Neill, and Elizabeth M. Burke
- Subjects
medicine.medical_specialty ,Aspirin ,Papular eruption ,integumentary system ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Physical examination ,Dermatology ,General Medicine ,Rash ,Trunk ,Linear array ,Surgery ,medicine.anatomical_structure ,medicine ,medicine.symptom ,Oral mucosa ,business ,Topical steroid ,medicine.drug - Abstract
REPORT OF A CASE A 71-year-old man was hospitalized because of a transient ischemic attack. The dermatology department was consulted to evaluate an eruption on the left side of the trunk that was thought to be herpes zoster. The rash had appeared abruptly 6 months earlier and had failed to respond to topical steroid treatment. There was no history of previous skin disease or other illness. The patient's only medication was aspirin. Physical examination revealed grouped 2- to 4-mm red-brown, scaly papules in a linear array overlying the left flank (Figure 1). There were no abnormalities of the nails or oral mucosa. A punch biopsy was performed (Figure 2). What is your diagnosis?
- Published
- 1997
17. Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy.
- Author
-
Matthew McKay, Sean Pinney, Simon Gorwara, Elizabeth M Burke, Robert R Sciacca, Mark Apfelbaum, Donna Mancini, Silviu Itescu, and LeRoy E Rabbani
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.